Haloprogin
Template:Short description Lua error in package.lua at line 80: module 'Module:Hatnote list' not found. Template:Short description Page Template:Infobox drug/styles.css has no content.
Page Module:Infobox/styles.css has no content.
| Lua error in package.lua at line 80: module 'Module:InfoboxImage/data' not found. | |
| Clinical data | |
|---|---|
| Routes of administration | Topical |
| ATC code | Page Template:Plainlist/styles.css has no content. |
| Legal status | |
| Legal status | Page Template:Plainlist/styles.css has no content. |
| Identifiers | |
| |
| CAS Number | Page Template:Plainlist/styles.css has no content. |
| PubChem CID | Page Template:Plainlist/styles.css has no content. |
| PubChem SID | Page Template:Plainlist/styles.css has no content. |
| IUPHAR/BPS | Page Template:Plainlist/styles.css has no content. |
| DrugBank | Page Template:Plainlist/styles.css has no content. |
| ChemSpider | Page Template:Plainlist/styles.css has no content. |
| UNII | Page Template:Plainlist/styles.css has no content. |
| KEGG | Page Template:Plainlist/styles.css has no content. |
| ChEBI | Page Template:Plainlist/styles.css has no content. |
| ChEMBL | Page Template:Plainlist/styles.css has no content. |
| NIAID ChemDB | Page Template:Plainlist/styles.css has no content. |
| PDB ligand | Page Template:Plainlist/styles.css has no content. |
| CompTox Dashboard (EPA) | Page Template:Plainlist/styles.css has no content. |
| Chemical and physical data | |
| Formula | C9H4Cl3IO |
| Molar mass | 361.38 g·mol−1 |
| 3D model (JSmol) | Page Template:Plainlist/styles.css has no content. |
| Melting point | 113.5 °C (236.3 °F) |
| Solubility in water | Insoluble mg/mL (20 °C) |
| |
| |
| Data page | |
| Template:Infobox drug/data page link | |
| Page Template:Nobold/styles.css has no content. (verify) | |
Haloprogin is an antifungal drug used to treat athlete's foot and other fungal infections.[1] It is marketed in creams under the trade names Halotex, Mycanden, Mycilan, and Polik.
Action
Haloprogin was previously used in 1% topical creams as an antifungal agent. It was marketed over-the-counter primarily to treat tinea infections of the skin. The mechanism of action is unknown.[2]
Haloprogin had a high incidence of side effects including: irritation, burning, vesiculation (blisters), scaling, and itching. It has since been discontinued due to the emergence of more modern antifungals with fewer side effects.[3]
References
- ^ Page Module:Citation/CS1/styles.css has no content.Rudolph RI (December 1979). "Haloprogin as treatment for fungal infections". Clinical and Experimental Dermatology. 4 (4): 548. doi:10.1111/j.1365-2230.1979.tb01656.x. PMID 161212. S2CID 71471801.
- ^ Page Module:Citation/CS1/styles.css has no content."Haloprogin". Drugs@FDA. Food and Drug Administration. Archived from the original on September 26, 2006. Retrieved 2007-02-17.
- ^ Page Module:Citation/CS1/styles.css has no content."Haloprogin". DrugBank. University of Alberta. Nov 6, 2006. Retrieved 2007-02-17.
Lua error in package.lua at line 80: module 'Module:Navbox/configuration' not found. Template:Xenobiotic-sensing receptor modulators